Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001493152-24-035484
Filing Date
2024-09-09
Accepted
2024-09-09 16:35:08
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-09-09

Document Format Files

Seq Description Document Type Size
1 formars.pdf ARS 2177087
  Complete submission text file 0001493152-24-035484.txt   2999926
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41184 | Film No.: 241287664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)